Peptides-ACE031-1mg × 10 vial


ACE-031 is an investigational protein therapeutic that is being developed by Acceleron Pharma for the treatment of Duchenne Muscular Dystrophy (DMD).

The drug received orphan designation from the US Food and Drug Administration (FDA) for treating DMD disease in August 2010.



There are no reviews yet.

Be the first to review “Peptides-ACE031-1mg × 10 vial”

Your email address will not be published. Required fields are marked *